We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).AuthorsYchou, M.; Raoul, J. -L.; Douillard, J. -Y.; Gourgou-Bourgade, S.; Bugat, R.; Mineur, L.; Viret, F.; Becouarn, Y.; Bouché, O.; Gamelin, E.; Ducreux, M.; Conroy, T.; Seitz, J. -F.; Bedenne, L.; Kramar, A.PublicationAnnals of Oncology, 2009, Vol 20, Issue 4, p674ISSN0923-7534Publication typearticleDOI10.1093/annonc/mdn680